The latest Taboo & Repugnant Roundup includes three items that span organ transplantation, end-of-life law, and the classroom.
First is further discussion of the New York Times profile of the National Kidney Registry, including its technological model, voucher and “bonus kidney” programs, and the litigation that has arisen from hospital contracts. These cases highlight unresolved questions about damages, specific performance, and public policy in settings where market valuation is legally barred.
Second, the roundup notes New York’s forthcoming medical aid in dying statute, outlining the key features of the law and the safeguards that will govern its implementation once it takes effect.
Finally, the post ends with a brief and intentionally unserious New Year’s aside involving an AI tool that transformed course material on repugnant markets into a mock magazine cover.